Behavioral side effects of gabapentin in children

Epilepsia
D O LeeM A Mikati

Abstract

We report 7 children who received gabapentin (GBP) as adjunctive medic ation and subsequently developed behavioral side effects. These behavioral changes consisted of intensification of baseline behaviors as well as new behavioral problems. Behaviors that parents considered most troublesome were tantrums, aggression directed toward others, hyperactivity, and defiance. All behavioral changes were reversible and were managed by dose reduction or discontinuation of GBP. All children had baseline attention deficit hyperactivity disorder and developmental delays.

Citations

Oct 19, 2007·Neuropsychology Review·David W LoringKimford J Meador
Sep 17, 2002·Current Psychiatry Reports·Edward Kim
Oct 7, 2003·Epilepsy & Behavior : E&B·Gholam Motamedi, Kimford Meador
Jan 13, 1999·Pediatric Clinics of North America·R A Kowatch, J P Bucci
Dec 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·GianPietro SechiGiulio Rosati
Dec 22, 1999·Epilepsy Research·E Korn-MerkerH E Boenigk
Nov 5, 1997·Seminars in Pediatric Neurology·G L Holmes
Mar 1, 2003·Epilepsy & Behavior : E&B·Josiane LaJoie, Daniel K. Miles
Mar 1, 2003·Epilepsy & Behavior : E&B·Laura S. BoylanTerence A. Ketter
Aug 17, 2004·Epilepsy Currents·Michele Sammaritano
Aug 20, 2011·Journal of Child and Adolescent Psychopharmacology·Daniel J Safer
Jun 8, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·A A WeissenbergerA J Zametkin
Aug 15, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·D OttS Chayasirisobhon
Jul 14, 1999·Epilepsia·N Chevassus-au-LouisY Ben-Ari
Nov 16, 2006·Epilepsia·Bettina Schmitz
Sep 22, 2005·Epilepsy Currents·Siddhartha Nadkarni, Orrin Devinsky
Sep 1, 1996·Archives of Disease in Childhood·R E Appleton
Jan 1, 2000·International Journal of Adolescent Medicine and Health·James J Riviello
Aug 11, 2000·Pharmacotherapy·J M Pellock
Aug 11, 2000·Paediatric Drugs·B Bar-OzS Ito
Oct 14, 2005·Paediatric Drugs·Arman Danielyan, Robert A Kowatch
Mar 3, 2010·CNS Drugs·Dean P Sarco, Blaise F D Bourgeois
Jan 18, 2008·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·David R P Guay
Aug 16, 2001·Brain & Development·S J Wallace
Jul 18, 2003·Clinical Therapeutics·Michael J McLean, Barry E Gidal
Dec 3, 2009·Expert Review of Neurotherapeutics·Hesham M HamodaJoseph Gonzalez-Heydrich
Sep 10, 2010·Pharmaceuticals·Kaizad R MunshiJoseph Gonzalez-Heydrich
Jul 3, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marco Mula, Josemir W Sander
Jul 29, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·I C Wong, S D Lhatoo
Jul 11, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·F M Besag
Mar 13, 2003·Mayo Clinic Proceedings·Randa G Jarrar, Jeffrey R Buchhalter
Dec 21, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Udo BonnetMarkus Banger
Oct 29, 2010·Developmental Disabilities Research Reviews·Dewi Frances T Depositario-Cabacar, Tesfaye-Getaneh Zelleke
Dec 21, 2004·Pediatric Neurology·Romaine Schubert
Nov 29, 2015·Neurologic Clinics·Sai Krishna J Munjampalli, Debra E Davis
Nov 7, 1999·The Psychiatric Clinics of North America·L SanchezR Weller
Apr 6, 2004·The Psychiatric Clinics of North America·Elizabeth B WellerRonald A Weller
Jan 5, 2002·Neurological Research·J A Dougherty, D H Rhoney
May 5, 2001·Expert Opinion on Pharmacotherapy·K D Chang, T A Ketter
Oct 18, 2000·Seizure : the Journal of the British Epilepsy Association·E TrinkaG Bauer
Jan 1, 1997·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·C D Ferrie, J H Livingston
Oct 11, 2011·Seizure : the Journal of the British Epilepsy Association·J K A MillsW P Whitehouse
Aug 24, 1999·Seizure : the Journal of the British Epilepsy Association·A KhanR Kuzniecky
Oct 25, 2012·Epilepsy & Behavior : E&B·Piero Perucca, Marco Mula

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.